Integrated Health Care for PTSD

NCT ID: NCT07220681

Last Updated: 2025-10-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-05

Study Completion Date

2029-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to determine whether which types of integrative care, meaning a combination of psychotherapy and mind-body interventions, lead to the most changes in functioning among Veterans with posttraumatic stress disorder (PTSD). The main aims are:

1. To evaluate the impact of integrative care approaches on functional outcomes among Veterans with PTSD.
2. To examine factors relevant to the implementation of integrated treatments for PTSD from the perspective of patients, providers and administrators in the VA Healthcare System.

Participants will:

1. Complete assessments at the beginning of the study and 12- and 24-weeks later.
2. Engage in 12 weeks of integrated care, with the type being randomly assigned.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Posttraumatic Stress Disorder (PTSD)

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

PTSD complementary and integrative health Veterans implementation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

* Hybrid Type 1 study, simultaneously assessing efficacy and gathering information relevant to implementation
* "Drop the loser" adaptive design, whereby any experimental condition lagging behind the other conditions will be discontinued after interim analysis
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Usual care

Information about local and national complementary and integrative health programs

Group Type ACTIVE_COMPARATOR

Information

Intervention Type OTHER

Provision of written information about local and national complementary and integrative care resources

Yoga and meditation

Hatha yoga classes via videoconferencing and self-learning of Mantram Repetition Program

Group Type EXPERIMENTAL

Yoga and meditation

Intervention Type BEHAVIORAL

12 weekly 60-minute hatha yoga classes and access to video-based training in a portable mantra-based meditation practice

Information

Intervention Type OTHER

Provision of written information about local and national complementary and integrative care resources

Wellness

Weekly exercise/nutrition classes to support lifestyle changes

Group Type EXPERIMENTAL

Wellness

Intervention Type BEHAVIORAL

12 weekly 60-minute classes to provide education about exercise and nutrition and facilitate lifestyle changes

Information

Intervention Type OTHER

Provision of written information about local and national complementary and integrative care resources

Positive affect

Weekly classes focused on increasing positive affect and social support

Group Type EXPERIMENTAL

Positive affect

Intervention Type BEHAVIORAL

12 weekly 60-minute classes to teach strategies for increasing positive affect and to provide social connection

Information

Intervention Type OTHER

Provision of written information about local and national complementary and integrative care resources

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Yoga and meditation

12 weekly 60-minute hatha yoga classes and access to video-based training in a portable mantra-based meditation practice

Intervention Type BEHAVIORAL

Wellness

12 weekly 60-minute classes to provide education about exercise and nutrition and facilitate lifestyle changes

Intervention Type BEHAVIORAL

Positive affect

12 weekly 60-minute classes to teach strategies for increasing positive affect and to provide social connection

Intervention Type BEHAVIORAL

Information

Provision of written information about local and national complementary and integrative care resources

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* clinical diagnosis
* eligibility for Cognitive Processing Therapy (CPT) at a participating VA site
* able to consent to study activities

Exclusion Criteria

* current, active engagement in one of the included approaches (per clinician judgment)
* medical conditions that contraindicate engaging in the experimental interventions
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

United States Department of Defense

FED

Sponsor Role collaborator

Veterans Medical Research Foundation

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

VA Phoenix Healthcare System

Phoenix, Arizona, United States

Site Status

VA Central Arkansas Healthcare System

Little Rock, Arkansas, United States

Site Status

VA San Diego Healthcare System

San Diego, California, United States

Site Status

VA Portland Healthcare System

Portland, Oregon, United States

Site Status

VA North Texas Healthcare System

Dallas, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ariel J Lang, PhD, MPH

Role: CONTACT

Phone: 858-552-8585

Email: [email protected]

Haley Suit, MA

Role: CONTACT

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Brandi Luedtke, PhD

Role: primary

Kathleen Grubbs, PhD

Role: primary

Brandon Griffin, PhD

Role: backup

Ariel J Lang, PhD, MPH

Role: primary

Maya O'Neil, PhD

Role: primary

Bella Etingen, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HT94252510881

Identifier Type: -

Identifier Source: org_study_id